Takeda Pharmaceutical Company Limited (4502.T)
JPY 4093.0
(-0.1%)
JPY 4093.0
(-0.1%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2184.96 Billion JPY | -21.5% |
| 2022 | 2783.4 Billion JPY | 13.05% |
| 2021 | 2462.16 Billion JPY | 11.74% |
| 2020 | 2203.5 Billion JPY | 0.09% |
| 2019 | 2201.42 Billion JPY | 53.14% |
| 2018 | 1437.53 Billion JPY | 12.78% |
| 2017 | 1274.61 Billion JPY | 8.63% |
| 2016 | 1173.29 Billion JPY | -7.76% |
| 2015 | 1271.97 Billion JPY | 1.2% |
| 2014 | 1256.83 Billion JPY | 4.61% |
| 2013 | 1201.42 Billion JPY | 8.27% |
| 2012 | 1109.63 Billion JPY | 3.15% |
| 2011 | 1075.73 Billion JPY | -2.37% |
| 2010 | 1101.8 Billion JPY | -6.7% |
| 2009 | 1180.9 Billion JPY | -5.44% |
| 2008 | 1248.79 Billion JPY | 13.92% |
| 2007 | 1096.17 Billion JPY | 6.89% |
| 2006 | 1025.5 Billion JPY | 10.26% |
| 2005 | 930.1 Billion JPY | 10.23% |
| 2004 | 843.78 Billion JPY | 3.27% |
| 2003 | 817.03 Billion JPY | 9.56% |
| 2002 | 745.73 Billion JPY | 11.77% |
| 2001 | 667.2 Billion JPY | 15.14% |
| 2000 | 579.46 Billion JPY | 18.07% |
| 1999 | 490.79 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 639.31 Billion JPY | -2.87% |
| 2024 Q1 | 658.2 Billion JPY | 36.66% |
| 2023 FY | 2184.96 Billion JPY | -21.5% |
| 2023 Q1 | 737.5 Billion JPY | 14.1% |
| 2023 Q4 | 481.62 Billion JPY | -34.18% |
| 2023 Q3 | 731.7 Billion JPY | 4.6% |
| 2023 Q2 | 699.5 Billion JPY | -5.15% |
| 2022 FY | 2783.4 Billion JPY | 13.05% |
| 2022 Q1 | 679.58 Billion JPY | 20.3% |
| 2022 Q2 | 696.86 Billion JPY | 2.54% |
| 2022 Q3 | 760.57 Billion JPY | 9.14% |
| 2022 Q4 | 646.38 Billion JPY | -15.01% |
| 2021 Q3 | 619.89 Billion JPY | 8.94% |
| 2021 FY | 2462.16 Billion JPY | 11.74% |
| 2021 Q1 | 708.33 Billion JPY | 37.06% |
| 2021 Q2 | 569.02 Billion JPY | -19.67% |
| 2021 Q4 | 564.9 Billion JPY | -8.87% |
| 2020 FY | 2203.5 Billion JPY | 0.09% |
| 2020 Q4 | 516.82 Billion JPY | -11.44% |
| 2020 Q1 | 563.77 Billion JPY | 7.69% |
| 2020 Q2 | 539.29 Billion JPY | -4.34% |
| 2020 Q3 | 583.61 Billion JPY | 8.22% |
| 2019 Q1 | 548.52 Billion JPY | 28.35% |
| 2019 FY | 2201.42 Billion JPY | 53.14% |
| 2019 Q3 | 579.74 Billion JPY | 7.49% |
| 2019 Q2 | 539.33 Billion JPY | -1.68% |
| 2019 Q4 | 523.52 Billion JPY | -9.7% |
| 2018 Q4 | 427.37 Billion JPY | 18.42% |
| 2018 FY | 1437.53 Billion JPY | 12.78% |
| 2018 Q2 | 320.02 Billion JPY | -2.8% |
| 2018 Q1 | 329.24 Billion JPY | 13.5% |
| 2018 Q3 | 360.88 Billion JPY | 12.77% |
| 2017 Q3 | 345.86 Billion JPY | 11.1% |
| 2017 FY | 1274.61 Billion JPY | 8.63% |
| 2017 Q1 | 327.37 Billion JPY | 16.17% |
| 2017 Q2 | 311.3 Billion JPY | -4.91% |
| 2017 Q4 | 290.07 Billion JPY | -16.13% |
| 2016 Q4 | 281.79 Billion JPY | -11.26% |
| 2016 Q2 | 275.33 Billion JPY | -7.8% |
| 2016 FY | 1173.29 Billion JPY | -7.76% |
| 2016 Q1 | 298.61 Billion JPY | 6.21% |
| 2016 Q3 | 317.55 Billion JPY | 15.33% |
| 2015 FY | 1271.97 Billion JPY | 1.2% |
| 2015 Q4 | 281.15 Billion JPY | -18.31% |
| 2015 Q3 | 344.18 Billion JPY | 7.07% |
| 2015 Q2 | 321.46 Billion JPY | -1.14% |
| 2015 Q1 | 325.17 Billion JPY | 7.23% |
| 2014 Q4 | 303.25 Billion JPY | -13.16% |
| 2014 FY | 1256.83 Billion JPY | 4.61% |
| 2014 Q1 | 293.1 Billion JPY | 7.03% |
| 2014 Q2 | 311.25 Billion JPY | 6.19% |
| 2014 Q3 | 349.21 Billion JPY | 12.19% |
| 2013 FY | 1201.42 Billion JPY | 8.27% |
| 2013 Q3 | 327.28 Billion JPY | 9.97% |
| 2013 Q2 | 297.6 Billion JPY | 0.81% |
| 2013 Q1 | 295.21 Billion JPY | 14.83% |
| 2013 Q4 | 273.86 Billion JPY | -16.32% |
| 2012 FY | 1109.63 Billion JPY | 3.15% |
| 2012 Q1 | 294.97 Billion JPY | 16.52% |
| 2012 Q2 | 275.89 Billion JPY | -6.47% |
| 2012 Q4 | 257.08 Billion JPY | -8.73% |
| 2012 Q3 | 281.67 Billion JPY | 2.09% |
| 2011 Q4 | 253.14 Billion JPY | -9.48% |
| 2011 Q3 | 279.65 Billion JPY | 5.68% |
| 2011 FY | 1075.73 Billion JPY | -2.37% |
| 2011 Q2 | 264.61 Billion JPY | -4.92% |
| 2011 Q1 | 278.31 Billion JPY | 8.99% |
| 2010 Q3 | 282.99 Billion JPY | 0.41% |
| 2010 FY | 1101.8 Billion JPY | -6.7% |
| 2010 Q4 | 255.36 Billion JPY | -9.76% |
| 2010 Q1 | 281.59 Billion JPY | 5.24% |
| 2010 Q2 | 281.84 Billion JPY | 0.09% |
| 2009 Q2 | 307.43 Billion JPY | -0.07% |
| 2009 Q4 | 267.58 Billion JPY | -10.28% |
| 2009 Q3 | 298.24 Billion JPY | -2.99% |
| 2009 FY | 1180.9 Billion JPY | -5.44% |
| 2009 Q1 | 307.64 Billion JPY | 15.09% |
| 2008 Q2 | 338.17 Billion JPY | 0.0% |
| 2008 Q4 | 267.3 Billion JPY | -17.77% |
| 2008 Q3 | 325.05 Billion JPY | -3.88% |
| 2008 FY | 1248.79 Billion JPY | 13.92% |
| 2007 FY | 1096.17 Billion JPY | 6.89% |
| 2006 FY | 1025.5 Billion JPY | 10.26% |
| 2005 FY | 930.1 Billion JPY | 10.23% |
| 2004 FY | 843.78 Billion JPY | 3.27% |
| 2003 FY | 817.03 Billion JPY | 9.56% |
| 2002 FY | 745.73 Billion JPY | 11.77% |
| 2001 FY | 667.2 Billion JPY | 15.14% |
| 2000 FY | 579.46 Billion JPY | 18.07% |
| 1999 FY | 490.79 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -4381.8% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | -1062.334% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | -491.994% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -61607.45% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | -2152.149% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -5616.517% |
| Eisai Co., Ltd. | 586.41 Billion JPY | -272.595% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -36328.259% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | -2666.797% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -4096.211% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -16064.585% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -28136.844% |
| Tsumura & Co. | 68.81 Billion JPY | -3075.04% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -5751.389% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -8713.194% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | -2584.795% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -13130.197% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -4254.144% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -4150.909% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -202399.259% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -22107.206% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -49434.347% |
| MedRx Co., Ltd | 26 Million JPY | -8403619.231% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -27124.571% |
| Solasia Pharma K.K. | 337 Million JPY | -648258.16% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 298901194.391% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -7025.28% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -3922.473% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -5788812.145% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | -1833.856% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -32808.102% |